Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12564/226
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPiechota, Wiesław-
dc.contributor.authorKrzesiński, Paweł-
dc.contributor.authorWoźniak-Kosek, Agnieszka-
dc.contributor.authorWójtowicz, Magdalena-
dc.contributor.authorDzierżanowska, Małgorzata-
dc.contributor.authorLiteracki, Sławomir-
dc.date.accessioned2021-02-18T10:03:40Z-
dc.date.available2021-02-18T10:03:40Z-
dc.date.issued2018-
dc.identifier.citationLekarz Wojskowypl
dc.identifier.issn0024-0745-
dc.identifier.urihttp://hdl.handle.net/20.500.12564/226-
dc.descriptionLicencja CC-BY-NC-SApl
dc.description.abstractOxidative stress promotes atherogenesis in diabetes. The aim of our study was to assess if there is increased lipid peroxidation and/or antioxidant depletion in diabetic patients and to establish whether these processes are interrelated and correlated with glycemic control. In 135 patients with type 2 diabetes and 64 non‑diabetic controls we determined lipid peroxidation products in plasma (LPO), serum total antioxidants (TAS), glycated hemoglobin (HbA1c) fructosamine, glucose, lipids (total cholesterol, triglycerides, and HDL cholesterol) and apolipoproteins A‑I and B. LPO (sum of malondialdehyde and 4‑hydroxynonenal) were significantly elevated in diabetics (1.34 ±0.51 vs 1.02 ±0.37 μmol/L; p <0.001). Serum total antioxidant status (TAS) remained unchanged in diabetes. Neither LPO nor TAS was correlated with glycated hemoglobin HbA1c, fructosamine, and fasting glucose. No correlation was observed between LPO and TAS. HDL‑cholesterol and apolipoprotein A‑I were decreased in diabetics. Our results showed increased lipid peroxidation in type 2 diabetes without measurable antioxidants depletion and without association with glycemic control. Furthermore, the results suggest that peroxidation and glycation may operate independently as atherosclerosis promoters in diabetes.pl
dc.language.isoplpl
dc.relation.ispartofseries2018 : T. 96, nr 1, s. 14-18;-
dc.rightsUznanie autorstwa-Użycie niekomercyjne-Na tych samych warunkach 3.0 Polska*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/3.0/pl/*
dc.subjectcukrzyca typu 2 - krewpl
dc.subjectperoksydacja lipidowapl
dc.subjectantyoksydanty - analizapl
dc.subjectglikemiapl
dc.subjectnadtlenki lipidówpl
dc.subjectendokrynologiapl
dc.titleLipid peroxidation, total antioxidant status, and glycemic control in patients with type 2 diabetes mellituspl
dc.title.alternativePeroksydacja lipidów, całkowity potencjał antyoksydacyjny i kontrola glikemii u pacjentów z cukrzycą typu 2pl
dc.typeinfo:eu-repo/semantics/articlepl
Appears in Collections:2018 rok

Files in This Item:
File Description SizeFormat 
014_2_Piechota.pdf168.87 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons